Skip to content

Mechanisms of Psoriatic Arthritis Progression and Identification of Potential Therapeutic Targets

Mechanisms of Psoriatic Arthritis Progression and Identification of Potential Therapeutic Targets

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124935
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriatic arthritis (joint pain, morning stiffness)

Interventions

Psoriatic arthritis PsA :None
Psoriasis PsO:None
Rheumatoid arthritis RA :None
Ankylosing spondylitis AS :None
Healthy controls:None

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PsA Group: Meets the CASPAR (Classification of Psoriatic Arthritis) criteria. PsO Group: Meets the diagnostic criteria described in the Chinese Medical Association's Guidelines for the Diagnosis and Treatment of Psoriasis in China (2023 Edition), with no clinical or imaging evidence satisfying CASPAR or rheumatologist-confirmed PsA. AS Group: Meets the assessment criteria for AS from the Assessment of SpondyloArthritis international Society (ASAS) (imaging positive or HLA-B27 characteristic), with no history of psoriasis. RA Group: Meets the 2010 ACR/EULAR RA classification criteria, with no history of psoriasis. Healthy Control Group (HC): Individuals with no history of psoriasis, psoriatic arthritis, or other systemic inflammatory diseases.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Secondary

MeasureTime frame
Single-cell transcriptomic features;Differentially expressed metabolomic features;Disease-related clinical phenotypic features;Post-translational modification omics features;Differentially expressed proteomic features;Gut microbiome features;Inflammatory laboratory parameters;

Countries

China

Contacts

Public ContactMeng Xu

The First Affiliated Hospital of Zhengzhou University

xumeng2106@163.com+86 371 6773 9138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026